On January 2, 2018, Bio-Techne, the parent company of R&D Systems, proudly announced its acquisition of Atlanta Biologicals, Inc. As noted by Bio-Techne President and Chief Executive Officer, Charles R. Kummeth, "Atlanta Biologicals is a great fit with the Bio-Techne product portfolio as we continue to expand our cell culture and tissue regeneration capabilities. Many of our products are used in tissue culture applications and the Atlanta Biologicals fetal bovine serum (FBS) product line strengthens and complements our current tissue culture reagents offering and furthers our efforts to provide more complete solutions...
- Products
- Products by Category
- Products by Research Area
- Our Products
- Services
- All Custom Services
- Custom Protein Services
- Luminex Custom Services
- Custom Antibody Services
- Assay Custom Services
- Custom Services for Cell & Gene Therapies
- Genome Engineering Services
- Custom Cell Culture Media Services
- Bioactivity Testing Services
- Chemistry Services
- Bulk/Custom Formulation
- Custom cDNA Cloning
Expedite Your Research
Expedite Your Research- Good Manufacturing Practice (GMP) Antibody Services
- Pathways
- Resources
- Research Areas
- Protocols/Troubleshooting Guides/Videos
- Technical Information
- Articles
- Help & FAQs
- Literature
- Request Literature
- Calculators
- Posters
- Blog
- Promotions
- Travel Grants
Posters, Brochures, Whitepapers & Reference Guides
Request Literature- Cell Markers
- New Lab Program
- R&D Systems Quality
- Quality Philosophy
- People
- Place
- Performance
- Product Development
- Customer Satisfaction
- The R&D Systems Quality Advantage
- Documents, Certifications, & FAQs
Experts in Reagent Quality
R&D Systems Quality
- About Us
- Careers
- Bio-Techne Brands
- Investor Relations
Our People are Our Greatest Asset
Join Us
- Contact Us